ArticleESMO real world data and digital oncology2025
JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan.
H Kitamura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it